{"id":"W4405364924","doi":"10.1016/j.msard.2024.106115","title":"154. Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results From the Phase 3 GEMINI 1 and 2 Trials","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); University of Toronto; St. Michael's Hospital","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Phase (matter); Internal medicine; Oncology; Fingolimod; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009682623,0.0006458413,0.001846354,0.0003435159,0.0004392756,0.0009733416,0.0005885821,0.002061927,0.01166311],"category_scores_gemma":[0.001445565,0.0003063508,0.00172216,0.0004044212,0.0003922601,0.000855612,0.00020349,0.00293146,0.002816894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008551294,"about_ca_system_score_gemma":0.0007208453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001152352,"about_ca_topic_score_gemma":0.004344275,"domain_scores_codex":[0.9996081,0.0001600119,0.00004154677,0.00006428693,0.00004458295,0.0000814857],"domain_scores_gemma":[0.9993487,0.0002349875,0.0001702551,0.00004236531,0.00005034048,0.0001533535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6114706,0.004075226,0.002930366,0.002805756,0.004061338,0.0002052629,0.00008703985,0.0008980815,0.01775004,0.0007302228,0.03126114,0.323725],"study_design_scores_gemma":[0.842979,0.09510741,0.02504934,0.0005523739,0.004226728,0.0003724,0.0000746153,0.001032929,0.004501415,0.00123097,0.02478704,0.00008571656],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8106095,0.09910923,0.001675917,0.01717629,0.00464737,0.002574995,0.01742484,0.0009894294,0.04579258],"genre_scores_gemma":[0.9307421,0.01856436,0.002594156,0.01541934,0.002346073,0.001511927,0.01002082,0.0001256987,0.01867566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01166311,"threshold_uncertainty_score":0.03901696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06294736156404931,"score_gpt":0.3237788504028992,"score_spread":0.2608314888388499,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}